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Assessment of microvessel density by immunohistochemical staining is subject to a considerable inter-observer variation, and
this has led to variability in correlation between microvessel density and clinical outcome in different studies. In order to
improve the method of microvessel density measurement in tumour biopsies, we have developed a rapid, objective and
quantitative method using ﬂow cytometry on frozen tissues. Frozen tissue sections of archival tumour material were
enzymatically digested. The single-cell suspension was stained for CD31 and CD34 for ﬂow cytometry. The number of
endothelial cells was quantiﬁed using light scatter- and ﬂuorescence-characteristics. Tumour endothelial cells were detectable
in a single cell suspension, and the percentage of endothelial cells detected in 32 colon carcinomas correlated highly (r=0.84,
P50.001) with the immunohistochemical assessment of microvessel density. Flow cytometric endothelial cells quantiﬁcation
was found to be more sensitive especially at lower levels of immunohistochemical microvessel density measurement. The
current method was found to be applicable for various tumour types and has the major advantage that it provides a
retrospective and quantitative approach to the angiogenic potential of tumours.
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Angiogenesis is essential for the outgrowth of tumours and metas-
tasis formation (Grifﬁoen and Molema, 2000). It has been
recognised that the angiogenic potential of a tumour contributes
to the aggressiveness of that tumour and may therefore be of prog-
nostic importance for various cancers. An increasing number of
studies have demonstrated that angiogenesis is predictive for the
clinical outcome of the disease, in the sense that an increased level
of angiogenesis is inversely related with survival (Weidner et al,
1992, 1993). In most of these studies, the angiogenic potential
was analysed by immunohistochemical determination of microves-
sel density (MVD) using antibodies recognising CD31, CD34 or
Von Willebrand Factor. This method is currently considered the
gold standard for this kind of studies. Although straightforward
and routinely performed in most diagnostic laboratories the immu-
nohistochemical MVD measurement has a number of
disadvantages. The method is laborious, difﬁcult to quantitate,
and suffers from considerable intra- and inter-observer variation.
This made an international agreement on performance of MVD-
analysis necessary (Vermeulen et al, 1996).
It is likely that the difﬁculties with this method have lead to a
substantial number of studies in which no correlation (Brechot et
al, 1996; Chandrachud et al, 1997; Hillen et al, 1997) or even an
inverse correlation (Sarbia et al, 1996; Delahunt et al, 1997) was
found between angiogenesis and the aggressiveness of the tumour.
This urged researchers to quantify MVD by using image-analysis soft-
ware (Kirchner et al, 1996; Wild et al, 2000;). Other methods to
measure angiogenesis in patients include detection of circulating
levels of angiogenic growth factors and soluble adhesion molecules,
magnetic resonance imaging and/or positron emission tomography
(van Dijke et al, 1996; Haubner et al, 2001). Major drawbacks of these
methods are the costs and the large variation of these measurements
in different patients. The current study describes a novel method to
efﬁciently quantify the number of endothelial cells (EC) in frozen
tumour biopsies using ﬂowcytometry. The ability to use archival
tissue is a major advantage in retrospective fundamental research.
MATERIALS AND METHODS
Preparation of single cell suspensions and ﬂow cytometry
Frozen tumour tissues were obtained from the stocks of the
Department of Pathology. Of each tumour two 10, 30 and/or
50 mm thick 0.5–1 cm
2 frozen tissue sections were either directly
digested or ﬁxed in 1 ml 1% paraformaldehyde (Sigma, Darmstadt,
Germany) in phosphate buffered saline (PBS) or 70% ethanol in
water for 1 h at room temperature prior to digestion. After ﬁxa-
tion, the sections were washed twice with 4 ml PBS and
centrifuged at 400 g. The sections were digested by incubation in
1 ml of different concentrations (1, 5 and 10 mg ml
71) of collage-
nase (Life Technologies, Breda, The Netherlands) and dispase (Life
Technologies) for time periods of 5–120 min at 378C during
repeated vigorous pipetting. After the digestion, the cells were
washed in 10 ml PBS/0.5% bovine serum albumin (BSA), centri-
fuged at 400 g and further processed on ice. Cell preparations
were microscopically evaluated for the condition of the single cell
suspension. Propidium iodide staining (permeabilisation in 70%
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iodide in PBS) was used to control for intact cells. Cell pellets were
incubated with 20 ml of appropriately diluted primary mouse
monoclonal antibodies. EC were identiﬁed by EN4 anti-human
CD31 antibody (1:80 hybridoma supernatant, Monosan, Uden,
The Netherlands) and QBEND-10 anti-human CD-34 antibody
(2 mgm l
71, Novocastra, Uden, The Netherlands). After two wash-
ings, the cells were incubated with 20 ml biotinylated rabbit anti-
mouse Ig antibodies (15 mgm l
71, Dako, Uithoorn, The Nether-
lands) for 1 h. Finally, the cells were stained with phycoerythrin
(PE)-conjugated streptavidine (10 mgm l
71, Dako) for 30 min.
Analysis was performed on a FACS-Calibur (Becton and Dickinson,
Mountain View, CA, USA). Both red (585 nm) and green
(530 nm) ﬂuorescence, forward light scatter and sidescatter were
recorded simultaneously of 10000 cells. Analysis of data was
performed using CellQuest-software (Becton and Dickinson).
Immunohistochemistry
Five mm serial cryo-sections, adjacent to the sections used for ﬂow
cytometry, were put on organosilane coated object slides, air-dried
for 24 h at room temperature and ﬁxed with 1% paraformaldehyde
(Sigma) for 1 h. Endogenous peroxidase was blocked by incubation
in 0,3% H2O2 in methanol for 30 min. Sections were blocked for
non-speciﬁc antibody binding with 5% BSA in PBS. The slides
were incubated in above mentioned antibodies for 1 h. After incu-
bation with avidine-biotin complex (Vector Laboratories Inc.) for
30 min, the slides were developed with diaminobenzidine (Sigma),
counterstained with haematoxylin (Merck, Darmstadt, Germany)
and the slides were mounted in entellan (Merck). The microvessel
density (MVD) was evaluated as described previously (Hillen et al,
1997). In short, two independent observers assessed MVD by either
counting of vessels in one high-power ﬁeld (1006) of three vascu-
lar hotspots of a section, or by enumeration of the total amount of
blood vessels in three high-power ﬁelds randomly selected within a
section. Correlation assessment was performed using the Pearson
correlation test. Signiﬁcance of observed differences were assessed
using the Student’s t-test.
RESULTS
EC quantiﬁcation by ﬂow cytometry
We have reported a technique for isolation and phenotyping of
endothelial cells (EC) from tumour biopsies (Grifﬁoen et al,
1996). For reasons of retrospective research we also wanted to
develop this method for frozen tissues. We adapted this technique
and the starting point of the investigations was the preparation of
thick cryo-sections and subsequent digestion with enzymes. In
order to ﬁnd the optimal thickness of the sections (too thin would
lead to damage of too many cells and too thick would lead to inap-
propriate digestion of the tissue), sections of 10, 30 and 50 mm
thickness were prepared. Sections were either directly digested or
ﬁxed in 1% paraformaldehyde or 70% ethanol at room temperature
prior to digestion. It was found that ﬁxation was needed, since less
measurable cells were left after omitting the ﬁxation procedure, due
to fragmentation. Fixation with paraformaldehyde gave optimal
results (not shown). Sections were digested for different time peri-
ods in different concentrations of the collagenase/dispase mix. We
found that 30 mm thick sections gave optimal results at all enzyme
concentrations. The optimal longevity and concentration of the
enzyme treatment was observed to be 15 min with 5 mg ml
71
collagenase and 5 mg ml
71 dispase (Table 1). Antibodies to
CD31 recognised a distinct subpopulation within the single cell
suspension (Figure 1A,B), which contains intact and single cells
as determined by propidium iodide staining (Figure 1C). The
CD31
+ cells are of endothelial origin since previous studies, using
fresh tissues have demonstrated that these cells are CD105
+ and
ICAM-2
+ and stain positive after DiI-acetylated-LDL incubation
(Grifﬁoen et al, 1996). The use of CD34 antibodies resulted in
generally lower amounts of stained cells, which was similar to the
immunohistochemistry data. However, using ﬂow cytometric analy-
sis a high correlation (r=0.73, P50.001) between the percentages of
CD31
+ and CD34
+ cells was observed (Figure 1D).
This technique of EC quantiﬁcation in tumour tissues was
applicable for tumours of multiple types and origins. Next to colon
carcinoma tissue, breast-, lung-, kidney-, head and neck-, ovarian-
and testis carcinomas were successfully analysed (not shown).
The analysis of EC percentages in tumour tissues by ﬂow cytome-
try was found to be highly reproducible. Variation in the percentage
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Table 1 Percentages of EC obtained by different procedures of single
cell preparation of colon carcinoma tissue
Collagenase and dispase concentration
Digestion time 1 mg ml
71a 5m gm l
71 10 mg ml
71
120 min Debris
b Debris Debris
90 min 5
c 2.5 Debris
60 min 7 3 2
30 min I.D. 9 4
15 min I.D. 11 5
5 min I.D. I.D. I.D.
aConcentration for both collagenase and dispase.
bNo evaluation due to fragmenta-
tion of cells.
cPercentage of CD31-positive EC in the single cell suspension.
I.D.=insufﬁcient digestion. The results of one representative experiment out of three
independent experiments are shown.
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Figure 1 Identiﬁcation of tumour EC. (A) Dot-plot of single cell suspen-
sion. Forward scatter (FSC) vs indirect CD31 staining (phycoerythrin, ver-
tical axis). (B) Conjugate control for the CD31 staining. (C) Propidium
iodide staining, revealing 495% of cells intact. (D) Positive correlation
(r=0.73, P50.001) of ﬂow-cytometrically identiﬁed EC using CD31 and
CD34 antibodies in 32 colon carcinomas.
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 87(3), 344–347of EC obtained by ﬂow cytometry was observed to be less than 5% of
the mean, when six independent measurements were performed on
one tumour. For example, one tumour analysed using CD31 antibo-
dies revealed a mean percentage of CD31-positive EC of 12.3% (s.d.
0.6%, n=6). For MVD assessment by immunohistochemistry a varia-
tion of 26% of the mean was observed.
Flow cytometric quantiﬁcation of EC correlates with
immunohistochemical MVD determination
To investigate whether our method correlates with the immunohis-
tochemical measurement of MVD, a series of 32 cryo-preserved
human colon carcinoma tissues (four Dukes A, 15 Dukes B, seven
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Figure 2 Immunohistochemistry and ﬂow cytometry and of a colon carcinoma with a high (A–C) and a low (D–F) vessel density. (A,D) Indirect CD31
immunohistochemical staining and counter staining of nuclei with hematoxilin. (B,E) Dot-plots of forward scatter vs indirect CD31 staining. (C,F) conjugate
controls.
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Figure 3 (A) Correlation diagram (r=0.74, P50.001) of percentage of ﬂow cytometrically identiﬁed EC and hotspot MVD measurement (mean number
of blood vessels in three hotspots per section). (B) Correlation diagram (r=0.84, P50.001) of ﬂow cytometrically identiﬁed EC and MVD measurement
(mean number of blood vessels per high-power ﬁeld). The mean results of 32 colon carcinomas are shown.
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density in a well differentiated colon carcinoma and high vascular
density in a poorly differentiated colon carcinoma are shown in
Figure 2.
A positive correlation between the percentage of EC and immu-
nohistochemical MVD assessment was observed. A high correlation
(r=0.74, P=0.001) was found when ﬂow cytometric analysis was
compared with MVD in vascular hotspots (Figure 3A). An even
higher correlation was found when the overall mean MVD was
compared (r=0.84, P50.001, Figure 3B). Interestingly, in the latter
case, the ﬂow cytometric analysis was found to be more sensitive
for tissues with low (59%) MVD measurements. For tissues with
high percentages of EC (49%), a higher correlation with immuno-
histochemical MVD assessment was observed (r=0.93, P50.002,
Figure 3B). A signiﬁcant correlation with tumour stage was not
found. Comparing the different methods, the currently described
new ﬂow cytometric technique is most beneﬁcial in the assessment
of angiogenesis in tumour tissues.
DISCUSSION
The capacity of a tumour to induce new blood vessel formation is
of key importance for its outgrowth and spread. The golden stan-
dard for analysis of angiogenesis, MVD assessment by
immunohistochemistry, has a number of disadvantages (see Intro-
duction). The current method is not subject to these problems. It
quantiﬁes the number of EC in frozen tissues accurately and objec-
tively. The high correlation with data obtained by
immunohistochemical analysis of MVD proved the speciﬁcity of
our method. Because the current method was set up to determine
the number of EC in an entire tissue section, the data obtained
should theoretically be most comparable to the data of the immu-
nohistochemical detection of the total mean number of vessels
(Figure 3B). Indeed, we found a higher correlation index than with
the hotspot countings. In this context two important considera-
tions should be mentioned. Firstly, the size of the blood vessels
may be critical. A tissue with a low number of large blood vessels
will be scored relatively low by immunohistochemical MVD
measurement, whereas, when oxygenation and/or metastasis is
concerned, this might be comparable to a higher number of smaller
vessels. Enumeration of EC by FACS may level this difference out.
Secondly, the nature and composition of the vessel might be criti-
cal. Larger vessels may be more mature and consequently contain
more extracellular matrix/basal membrane components that can
prevent the appropriate digestion and detachment of EC. This
may therefore be an intrinsic facilitation of the measurement of
angiogenic blood vessels. These two considerations both favour
the use of the currently described ﬂow cytometric analysis.
It might be argued that the CD31 antibody also identiﬁed other
cell types present in the tumour tissues such as leukocytes.
However, the immunohistochemistry data did not show staining
of leukocytes (see Figure 2). In addition, the leukocyte population
has most likely been excluded in the ﬂow cytometric analysis by
gating, due to lower scatter characteristics. Therefore, we still
favour the use of CD31 antibodies over CD34 antibodies.
Within the group of colon carcinoma tissues, which was selected
for representative cases of all Dukes stages, no correlations were
found between percentage of EC and Dukes stage, tumour size
or survival. This is most likely due to the study group size. Future
studies in large numbers of tumour tissues will provide informa-
tion on clinical parameters, which was beyond the scope of the
present study. The current method is potentially also suitable for
analysis of tumour EC phenotype. In future studies the number
and phenotype of EC in tumour biopsies before and after
chemotherapeutic and antiangiogenic treatment modalities will be
subject to investigations. This may reveal fundamental insights into
the regulation of angiogenesis or alternatively may provide surro-
gate endpoints of tumour treatments.
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